Navigation Links
SulphCo Adds New Board Member
Date:8/28/2008

HOUSTON, Aug. 28 /PRNewswire-FirstCall/ -- SulphCo, Inc. (the "Company" or "SulphCo") (Amex: SUF), a technology company with a patented ultrasound process to desulfurize crude oil, announced today the appointment of Fred S. Zeidman to the Company's Board of Directors.

"We are pleased to have Mr. Zeidman join SulphCo's Board of Directors," said Dr. Larry D. Ryan, Chief Executive Officer of SulphCo. "The Company will benefit from his extensive experience, both in the executive suite and the boardroom, along with his solid understanding of the energy business. I believe Mr. Zeidman will be a valuable asset in our future growth and development."

Mr. Zeidman has held leadership positions in a number of energy related companies. He is the former Chairman of the Board of Houston-based Seitel, Inc., a leading provider of seismic data and related geophysical expertise to the petroleum industry. He also served as Chairman of the Board of Unibar Corporation, the largest domestic independent drilling fluids company, until its sale in 1991 to Anchor Drilling Fluids. He currently serves as Interim President for Nova Biosource Fuels, Inc. (Amex), a refiner and marketer of renewable biodiesel fuel products. Mr. Zeidman is also a Senior Director for Governmental Affairs at Greenberg, Traurig's Washington D.C. law office.

"Having spent most of my career in the energy sector, I understand the value proposition of SulphCo's economical ultrasound solution to the complex and expensive problem of sulphur removal," said Zeidman. "I am excited to join the SulphCo Board and look forward to the opportunity to contribute to the success of this revolutionary technology as it transitions into the commercial phase."

An active participant in community, political and non-profit organizations, Mr. Zeidman currently serves as Chairman of the Holocaust Museum in Washington D.C. and Vice Chairman of the McCain for President Campaign. He also holds leadership roles in numerous non-profit organizations serving the arts, health care, academia and the Jewish community.

Mr. Zeidman is a graduate of Washington University and received an MBA from New York University. He currently lives in Houston with his wife and children.

About SulphCo, Inc.

The Company has developed a patented safe and economic process employing ultrasound technology to desulfurize and hydrogenate crude oil and other oil related products. The Company's technology is designed to upgrade sour heavy crude oils into sweeter, lighter crude oils, producing more gallons of usable oil per barrel.

From time to time, the Company may issue forward-looking statements, which involve risks and uncertainties. This statement may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as actual results could differ and any forward-looking statements should be considered accordingly.


'/>"/>
SOURCE SulphCo, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Regenerative Medicine Appoints Cell Therapy Group Consultant to Editorial Board
2. GM Exec Joins Bio-Reaction Industries Board of Directors
3. Regenesis Biomedical Announces Additions to Board of Directors
4. Medizone International, Inc. Appoints Dr. Michael E. Shannon to Its Board of Directors
5. XTL Biopharmaceuticals Receives Notice of Non-Compliance with Nasdaq Marketplace Rule Due to Changes in Board Composition
6. John Grisham Joins Focused Ultrasound Surgery Foundation Board, Citing Novel Technologys Potential to Help Millions of Patients
7. Omeros Appoints David A. Mann to its Board of Directors
8. Dr. Robert N. Butler Appointed to Board of Directors of BioTime, Inc.
9. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
10. ThermoGenesis Names Tiffany Olson to Board of Directors
11. SpineMark Appoints Dr. Rudolf Bertagnoli Chairman of International Medical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... NC (PRWEB) , ... June 24, 2016 , ... Researchers ... the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are ... to read it now. , Diagnostic biomarkers are signposts in the blood, lung ...
(Date:6/23/2016)... SPRING, Md. , June 23, 2016 A ... collected from the crime scene to track the criminal down. ... and the U.S. Food and Drug Administration (FDA) uses DNA ... Sound far-fetched? It,s not. The ... genome sequencing to support investigations of foodborne illnesses. Put as ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... June 23, 2016  Blueprint Bio, a company dedicated ... the medical community, has closed its Series A funding ... . "We have received a commitment from ... we need to meet our current goals," stated ... the runway to complete validation on the current projects ...
Breaking Biology Technology:
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/16/2016)... FRANCISCO , June 16, 2016 ... size is expected to reach USD 1.83 ... by Grand View Research, Inc. Technological proliferation and ... banking applications are expected to drive the market ... ) , The development of advanced ...
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
Breaking Biology News(10 mins):